Tower Research Capital (TRC)’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-39
Closed -$674 5596
2025
Q3
$674 Buy
39
+32
+457% +$545 ﹤0.01% 4964
2025
Q2
$129 Buy
+7
New +$130 ﹤0.01% 5131
2025
Q1
Sell
-4
Closed -$75 5780
2024
Q4
$75 Hold
4
﹤0.01% 5507
2024
Q3
$88 Hold
4
﹤0.01% 5526
2024
Q2
$82 Sell
4
-6
-60% -$119 ﹤0.01% 5508
2024
Q1
$201 Buy
+10
New +$192 ﹤0.01% 5592
2023
Q4
Sell
-45
Closed -$764 6163
2023
Q3
$764 Buy
+45
New +$836 ﹤0.01% 5479
2023
Q2
Sell
-5
Closed 6356
2023
Q1
$0 Buy
+5
New +$96 ﹤0.01% 6270
2022
Q4
Sell
-3
Closed 6374
2022
Q3
$0 Buy
+3
New +$60 ﹤0.01% 6484

Other funds holding THQ

Tower Research Capital (TRC)'s THQ Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of abrdn Healthcare Opportunities Fund (THQ) in Q4 2025, closing a stake of 39 shares — an estimated $674 sold.

Tower Research Capital (TRC) first reported a position in THQ in Q3 2022 and held it in 9 quarters. The position peaked at $764 in Q3 2023. 92 funds tracked by Wall St. Rank hold THQ as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining abrdn Healthcare Opportunities Fund position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 39 abrdn Healthcare Opportunities Fund shares in Q4 2025, an estimated $674.
  • Tower Research Capital (TRC) first reported a position in abrdn Healthcare Opportunities Fund in Q3 2022 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s abrdn Healthcare Opportunities Fund position peaked at $764 in Q3 2023.
  • 92 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.